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Abstract
Background: Coronary atherosclerosis and its thrombotic complications are the major cause of
mortality and morbidity throughout the industrialized world. Thrombosis on disrupted
atherosclerotic plaques plays a key role in the onset of acute coronary syndromes. Macrophages
density is one of the most critical compositions of plaque in both plaque vulnerability and
thrombogenicity upon rupture. It has been shown that macrophages have a high uptake of 18F-FDG
(FDG). We studied the correlation of FDG uptake with histopathological macrophage
accumulation in atherosclerotic plaques in a rabbit model.
Methods: Atherosclerosis was induced in rabbits (n = 6) by a combination of atherogenic diet and
balloon denudation of the aorta. PET imaging was performed at baseline and 2 months after
atherogenic diet and coregistered with magnetic resonance (MR) imaging. Normal (n = 3) rabbits
served as controls. FDG uptake by the thoracic aorta was expressed as concentration (µCi/ml) and
the ratio of aortic uptake-to-blood radioactivity. FDG uptake and RAM-11 antibody positive areas
were analyzed in descending aorta.
Results: Atherosclerotic aortas showed significantly higher uptake of FDG than normal aortas.
The correlation of aortic FDG uptake with macrophage areas assessed by histopathology was
statistically significant although it was not high (r = 0.48, p < 0.0001). When uptake was expressed
as the ratio of aortic uptake-to-blood activity, it correlated better (r = 0.80, p < 0.0001) with the
macrophage areas, due to the correction for residual blood FDG activity.
Conclusion: PET FDG activity correlated with macrophage content within aortic atherosclerosis.
This imaging approach might serve as a useful non-invasive imaging technique and potentially permit
monitoring of relative changes in inflammation within the atherosclerotic lesion.
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Background
Atherothrombosis, characterized by atherosclerotic lesion
disruption with superimposed thrombosis, is the main
cause of acute coronary syndromes (unstable angina,
myocardial infarction and sudden death) [1]. It represents
the major cause of morbidity and mortality in the indus-
trialized world. Experimental, pathological and clinical
studies have clearly demonstrated the heterogeneity of
atherosclerotic lesions [2]. Typically, the mature athero-
sclerotic plaque contains two different components: soft
lipid/macrophage-rich "atheromatous" material and hard
smooth muscle cell-related sclerotic tissue. Significant
advances have been made in understanding of mecha-
nisms underlying this disease process. The progression of
atherosclerotic plaques in coronary circulation is depend-
ent on a number of risk factors. It has been shown that the
atherosclerotic plaque composition rather than the degree
of arterial stenosis appears to be a critical determinant of
atherosclerotic plaque vulnerability and thrombogenicity
[1,3]. The current gold standard imaging technique for
atherosclerosis is x-ray contrast angiography, which pro-
vides high-resolution definition of the site and severity of
luminal stenoses, but no information about plaque com-
position. Thus other than ulcerated lesions, it cannot dif-
ferentiate between unstable and stable plaques and,
therefore, is unable to predict the risk of plaque rupture.
In order to assess the presence, extent and composition of
atherosclerotic lesions in patients, there is a clinical need
for a non-invasive diagnostic imaging technique which
can be used to assess the vulnerability of atherosclerotic
plaques [4]. It was reported that macrophages contribute
extensively to the development of inflammation in
plaques [5,6] and ruptured plaques have large numbers of
macrophages [7]. Several pathologic studies have clearly
demonstrated that macrophages play a key role in both
risk of plaque rupture and modulation of the plaque's
subsequent thrombogenicity [3,8]. Tissue factor present
in lipid-rich atherosclerotic plaques is important in acute
arterial thrombosis and correlates with the extent of areas
of macrophages [8,9]. Thus, macrophage density is con-
sidered an important determinant of plaque vulnerability.
It has been shown that macrophages of tumor tissue have
a high uptake of 18F-FDG (FDG) [10]. This discovery has
led to investigation of the possibility of using FDG to
image macrophages in atherosclerotic plaque. The objec-
tive of this study was to investigate the feasibility of using
FDG as a marker and using PET to assess the macrophage
burden in atherosclerotic lesions, and thereby to predict
their vulnerability.
Methods
Animal model of experimental atherosclerosis
The animal model selected for this study was New Zea-
land white rabbit (n = 9, 3.0 to 3.4 kg). Atherosclerotic
lesions were induced in six rabbits by a combination of a
moderate atherogenic diet (0.2% cholesterol-enriched
diet, Research Diet, Inc., New Brunswick, NJ, USA) for two
months and balloon denudation of the aorta one week
after diet initiation [11]. Three normal rabbits with nor-
mal diet and without balloon denudation of the aorta
served as controls. All procedures were performed under
general anesthesia by intramuscular injection of ketamine
(20 mg/kg) and xylazine (10 mg/kg). Aortic denudation
of the descending thoracic aorta was performed by with-
drawal, with moderate resistance, of a 4Fr Fogarty
embolectomy catheter introduced through the iliac artery
and passed into the aortic arch. Catheter insertion and
inflation were repeated for four passes, after which the
catheter was removed, the femoral artery tied, and the
incision closed. All experiments were approved by the
Mount Sinai School of Medicine animal management
program, under accreditation from the American Associa-
tion for the Accreditation of Laboratory Animal Care
(AALAC).
FDG PET imaging
After fasting the previous night, the rabbits were anesthe-
tized as described above. They were immobilized with a
body-fitting thermosetting plastic holder compatible with
both MR and PET scanning systems, thus assuring the
same positioning of the rabbits for both imaging studies.
Immediately before the FDG PET imaging, all rabbits
underwent MR imaging for the purpose of localization of
the anatomical structures on the PET images. The rabbits
were laser-aligned on the xiphi-sternum in both scanning
modalities. After initial gradient echo scout images to
identify the thoracic aorta, 2D-time of flight MR imaging
was performed to localize the aorta (field of view: 18 ×
11.25 cm; matrix 256 × 160; TR/TE: 46/4.4 msec, slice
thickness 2 mm; flip angle: 45°). The anesthetized rabbits
were then immediately taken to the PET scanner in the
holders. Imaging was performed using a GE 2048-plus
brain-dedicated PET scanner. Each rabbit was injected via
a marginal ear vein with 55.5 ± 7.4 MBq (1.5 ± 0.2 mCi)
of FDG. PET imaging of aorta was performed 30 min post
injection. Following transmission (30 min) and emission
(3 ten min images) acquisitions, the data were recon-
structed with standard filtered back projection and atten-
uation correction. Using an in-house software system,
each PET slice was co-registered with its corresponding
MR imaging slice [12]. Thus, anatomical structures identi-
fied by MR imaging were correlated with FDG images by
a process of image coregistration.
Blood sampling
Arterial blood samples were collected from an auricular
artery at 15, 30, 45, and 60 min post-injection of FDG.
Blood samples were weighed. The radioactivity was
counted in a γ counter (Minaxi Auto-Gamma 5000 Series
Gamma Counter, Packard, USA) and decay corrected.BMC Nuclear Medicine 2006, 6:3 http://www.biomedcentral.com/1471-2385/6/3
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Histopathology
To correlate the PET data with histopathological observa-
tions, rabbits were euthanized within 24 hours of PET
imaging by intravenous injection of 5 mL "Sleepaway" IV
(Fort Dodge Animal Health, Fort Dodge, IA) after admin-
istration of heparin (100 IU/kg) to prevent post-mortem
blood clotting. The aortas were immediately flushed with
250 ml of physiological buffer (0.1 mol/L PBS, pH 7.4)
followed by perfusion fixation with 250 ml cold (4°C)
4% paraformaldehyde in 0.1% PBS. Perfusions were per-
formed at 100 mmHg. The entire aorta from the aortic
root to the iliac arteries was excised. After perfusion fixa-
tion, all specimens were immersed in fresh fixative and
stored at 4°C. Serial sections of the aorta were cut at 6 mm
intervals, matching corresponding MR-PET images.
Coregistration was carefully performed, based on the
position of the aortic arch. Aortic specimens were embed-
ded in paraffin and sections 5-micron thick were cut. The
extent of atherosclerosis burden was confirmed by CME
staining macrophage content. Immunohistology was per-
formed using a monoclonal antibody directed against
macrophages (RAM-11) to assess macrophage content.
RAM-11 antibody (Dako North America, Inc., Carpinte-
ria, CA, USA) was diluted 1:1000 and visualized using
Horseradish Peroxidase ABC kit (Vector Laboratories, Bur-
lingame, CA, USA) as per manufacturer's instructions.
RAM-11 macrophage positive areas were measured using
a computer-assisted quantitative color image analysis sys-
tem (Image ProPlus, Media Cybernetics) and expressed in
mm2.
Data analysis
Regional analyses of MR-PET images were performed and
related this information to corresponding regional macro-
phage areas. The PET images were transferred to a PC com-
patible computer for further analysis. For the definition of
regions of interest (ROI) and data analysis, in-house com-
puter programs were used. ROIs of the aorta identified by
MR imaging were correlated with FDG PET images of the
same animal by image coregistration. Aortic uptake,
which was expressed as concentration (µCi/ml), was
measured for the eight consecutive upper sections of the
descending thoracic aorta (length 4.8 cm). Slices were 6
mm apart by taking a 5 × 5 mm2 ROI. For the correction
of blood pool activity, FDG uptake was also expressed as
the ratio of aortic uptake-to-blood radioactivity. The his-
topathological sections were digitized to a Macintosh
computer from a Sony 3CCD Video camera attached to a
Zeiss Axioskop light microscope. RAM-11 macrophage
positive areas were measured using a computer-assisted
quantitative color image analysis system (Image ProPlus,
Media Cybernetics) and expressed in mm2. FDG uptake
on each slice was correlated to the corresponding histo-
logical results.
Statistical analysis
The correlations between regional measurements by PET
and histopathology on the slices (n = 72) of descending
thoracic aorta of the rabbits were analyzed by simple lin-
ear regression with 95% confidence intervals (Statview,
SAS Institute Inc., Cary, NC, USA). A p value < 0.05 was
considered statistically significant.
Results
Atherosclerotic characterization by histology
In the control group, there were no atherosclerotic lesions
and no macrophages in the aortic wall. The combination
of an atherogenic diet and balloon denudation of the
aorta induced significant atherosclerosis. The induced
atherosclerotic lesions contained macrophages as indi-
cated by RAM-11 staining (Figure 1).
FDG PET imaging and coregistration of MRI and PET 
images
ROIs of the aorta identified by MR imaging were corre-
lated with FDG PET images of the same animal by image
coregistration (Figure 2). In FDG PET images, sagittal and
coronal sections of the descending aorta of atherosclerotic
rabbits (Figure 3B) demonstrated a higher uptake of FDG
than controls (Figure 3A).
Macrophage areas and FDG uptake
The correlation of aortic FDG uptake with macrophage
areas as measured by histopathology was statistically sig-
nificant but not high (r = 0.48, p < 0.0001)(Figure 4A).
Atherosclerotic Rabbit Aorta: RAM-11 staining Figure 1
Atherosclerotic Rabbit Aorta: RAM-11 staining.BMC Nuclear Medicine 2006, 6:3 http://www.biomedcentral.com/1471-2385/6/3
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Macrophage areas and the ratio of aortic uptake-to-blood 
radioactivity
When FDG uptake was expressed as the ratio of aortic
uptake-to-blood activity, a higher correlation (r = 0.80, p
< 0.0001) between the macrophage areas and the FDG
uptake ratio was observed (Figure 4B).
Discussion
An important mechanism responsible for the sudden and
unpredictable onset of acute thrombosis is plaque rupture
[1]. The risk of rupture depends more on the plaque's
composition rather than its size [1,3]. Rupture occurs
preferentially in plaques containing a soft, lipid-rich core
that is covered by a thin cap of fibrous tissue [3]. Com-
pared with intact caps, the ruptured ones usually are thin-
ner and contain less collagen, have fewer smooth muscle
cells and are heavily infiltrated by macrophage foam cells
[3,13]. These macrophages are activated, indicating ongo-
ing inflammation at the site of plaque disruption [9].
Advances in our understanding of the cell biology of
atherosclerosis have led the search for new imaging tech-
niques that can provide information about plaque com-
position. Several imaging methods have been adapted to
detect vulnerable atherosclerotic plaques [14]. However,
they are unable to provide information on cell biologic
evens that determine risk of plaque rupture. Different con-
stituents of atherosclerosis, including radiolabeled lipo-
proteins, monocytes, smooth muscle cells, platelets, and
fibrinogen have been used as potential plaque-imaging
agents. Recently, radiolabeled annexin [15] and peptide
[16] have also been studied to localize thrombus. How-
ever, these radiolabeled tracers and imaging technology
need to be improved for in vivo imaging and characteriza-
tion of atherosclerotic lesions.
Both deoxyglucose (DG) and FDG, which are analogs of
glucose, compete with glucose for uptake into metaboli-
cally active cells. FDG has been shown to be a substrate for
hexokinase [17], and is taken up into metabolically active
cells but is not further metabolized. As FDG accumulates
in the cells, its uptake is a measure of metabolic activity.
FDG has been widely used to estimate glucose metabo-
lism in heart, brain, and tumor tissue by PET. The mecha-
nism of accumulation of this tracer within the malignant
tissue is largely due to the enhanced rate of glucose utili-
zation by neoplastic cells [18]. Owing to increased meta-
bolic demand for glucose, hexokinase activity is increased.
Recent work using micro autoradiography has demon-
strated that macrophages, which are frequently found as
part of granulation tissue around the tumor, often showed
a higher uptake of FDG than even the tumor cells them-
selves [10]. Thus FDG might be used as a marker to quan-
tify macrophages in atherosclerotic lesions, and PET
Coregistration of MRI and PET images Figure 2
Coregistration of MRI and PET images. Coregistration of MRI and FDG PET images of a control (top) and an atheroscle-
rotic rabbit (bottom). Each row shows the fused dataset progressing from an anatomical MRI to a sole functional FDG PET 
image of the same animal in the same location. ROIs of the aorta (indicated with a blue circle and arrow) were identified on the 
MRI. The software automatically extracted the PET values from the same location in the PET image.BMC Nuclear Medicine 2006, 6:3 http://www.biomedcentral.com/1471-2385/6/3
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might be used to predict the vulnerability of atherosclero-
sis.
Due to the unavailability of a PET/CT scanner at the time,
this study was conducted using a dedicated brain PET
scanner, MR imaging was used for the localization of the
anatomical structures on the PET images and facilitated
regional analyses of PET images with histological results.
In our current study, in the control group there were no
atherosclerotic lesions and no macrophages in the aortic
wall. Normal rabbits did not show uptake above that of
background levels. The combination of an atherogenic
diet and balloon denudation of the aorta induced signifi-
cant atherosclerosis.
Atherosclerotic aortas showed significantly higher uptake
of FDG than normal aortas (Fig. 3). The atherosclerotic
plaques in the aorta of rabbits were well visualized. The
FDG uptake was not evenly distributed in the entire
descending atherosclerotic aorta (Fig. 3B). High uptake
was observed within the plaques, compared to uninjured
areas. When FDG uptake was expressed as concentration,
the correlation of aortic FDG uptake with macrophage
areas as measured by histopathology was statistically sig-
nificant but not high (r = 0.48, p < 0.0001) (Fig. 4A). It has
been reported [19] that blood FDG activity is high com-
pared to uptake in injured arterial segments in the experi-
mental rabbit model. Because the present PET imaging
was taken 30 min post-injection of FDG, the residual
blood activity and FDG uptake in surrounding tissues
might have impeded accurate quantification of aortic
uptake. To reduce the influence of blood pool and sur-
rounding structures, FDG uptake was expressed as the
ratio of aortic uptake-to-blood activity, and aortic uptake
was carefully measured from coregistered MR-PET images.
We found that the ratio of aortic uptake-to-blood activity
was better correlated to the macrophage areas assessed by
histopathology (r = 0.80, p < 0.0001) (Fig. 4B). Delayed
imaging, which allows more complete FDG clearance
from blood, could provide additional benefits for the
quantification of FDG uptake in aorta. Recent animal [20]
The correlation of macrophage areas and FDG uptake Figure 4
The correlation of macrophage areas and FDG 
uptake. Linear regression analyses showing the correlation 
of macrophage areas and FDG uptake in the segments (n = 
72) of descending thoracic aorta of the rabbits, expressed as 
concentration (µCi/ml) (A) (r = 0.48, p < 0.0001) and ratio of 


























































In vivo PET images Figure 3
In vivo PET images. In vivo PET sagittal (top) and coronal 
(bottom) images showing the uptake of FDG in the thoracic 
aorta in a control rabbit (A), in a rabbit with mild atheroscle-
rosis (B).
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and human FDG PET studies [21] of atherosclerotic
plaque has confirmed that quantification of FDG uptake
can be better achieved when performing imaging 210 min
and 190 min post-injection of FDG, respectively.
This preliminary study shows that FDG PET detects and
quantifies  in vivo macrophage content within aortic
atherosclerosis in an experimental rabbit model. Leder-
manet et al. [19] and Rudd et al. [21] have showed that tri-
tium-labeled glucose analogs accumulate in macrophage-
rich atherosclerotic plaques in vitro. Ogawa et al. [20]
recently investigated the relationship between the accu-
mulation of FDG and the pathologic characteristics of aor-
tic atherosclerotic lesions in Watanabe heritable
hyperlipidemic (WHHL) rabbits. Despite the animal
model being different from ours, they found that FDG
uptake was well correlated with the number of macro-
phages. This is consistent with the finding in our studies,
suggesting that macrophages are responsible for the accu-
mulation of FDG in atherosclerotic lesions. Recently a
clinical trial to detect atherosclerotic lesions by radionu-
clide imaging with FDG was also reported [21]. The study
shows that plaque macrophage activity, the major deter-
minant of plaque rupture, can be imaged by FDG PET.
Together these and our studies suggest that FGD PET has
the potential to monitor plaque inflammation in vivo, and
to provide invaluable metabolic and composition infor-
mation of the plaque. FGD PET then can assist in the strat-
ification of patients at risk of plaque rupture and
subsequent thrombosis. Furthermore, this promising
non-invasive imaging technique might be used to assess
serial progression and regression of macrophage content
in different experimental models as well as in humans.
Studies are currently under way to evaluate the potential
of FDG PET for this application.
Conclusion
PET FDG activity correlated with macrophage content
within aortic atherosclerosis. This imaging approach
might serve as a useful non-invasive imaging technique
and potentially permit monitoring of relative changes in
inflammation within the atherosclerotic lesion.
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